Glenmark to start new phase 3 clinical trial for hospitalised patients of moderate COVID-19
May 26, 2020
Mumbai (Maharashtra) [India], May 26 : Glenmark Pharmaceuticals on Tuesday announced a new randomised, open-label study to test the combined efficacy of two antiviral...